Known targets — ChEMBL curated mechanism
ACEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ATP4AATP4BAXLBTKCACNA1CCACNA1DCACNA1FCACNA1SCCR5CHRM2CHRM3CPT1BCPT2DPP4DRD1DRD2EGFRERBB2ERBB4FLT3HRH1HRH3HTR1AHTR2AHTR2BHTR2CHTR4JAK1JAK2JAK3KCNH2KMT2AMAP2K1MAP2K2MEN1MLNRMPLMTORPPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PLK4PPARGRENS1PR1SLC6A2SLC6A3SLC6A4SMOTYK2atpAatpBatpCatpDatpEatpFatpFHatpGpol
The experimentally established mechanism targets of Fumaric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNH2 known ✓ | Q12809 | 12/20 | 0.48 |
| ▸ | HRH1 known ✓ | P35367 | 2/20 | 0.39 |
| ▸ | MEN1 known ✓ | O00255 | 1/20 | 0.38 |
| ▸ | MLNR known ✓ | O43193 | 1/20 | 0.38 |
| ▸ | CACNA1F known ✓ | O60840 | 1/20 | 0.38 |
| ▸ | EGFR known ✓ | P00533 | 1/20 | 0.38 |
| ▸ | ERBB2 known ✓ | P04626 | 1/20 | 0.38 |
| ▸ | CHRM2 known ✓ | P08172 | 1/20 | 0.38 |
| ▸ | ADRB1 known ✓ | P08588 | 1/20 | 0.38 |
| ▸ | HTR1A known ✓ | P08908 | 1/20 | 0.38 |
| ▸ | ADRA2A known ✓ | P08913 | 1/20 | 0.38 |
| ▸ | DRD2 known ✓ | P14416 | 1/20 | 0.38 |
| ▸ | ADRA2B known ✓ | P18089 | 1/20 | 0.38 |
| ▸ | ADRA2C known ✓ | P18825 | 1/20 | 0.38 |
| ▸ | CHRM3 known ✓ | P20309 | 1/20 | 0.38 |
| ▸ | DRD1 known ✓ | P21728 | 1/20 | 0.38 |
| ▸ | SLC6A2 known ✓ | P23975 | 1/20 | 0.38 |
| ▸ | ADRA1D known ✓ | P25100 | 1/20 | 0.38 |
| ▸ | HTR2A known ✓ | P28223 | 1/20 | 0.38 |
| ▸ | HTR2C known ✓ | P28335 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9688967 | 0.93 | KCNH2 (0.52) | KCNH2SSTR5NR4A2EEDOPRK1 | |
| SCHEMBL9630331 | 0.84 | KCNH2 (0.54) | KCNH2SSTR5NR4A2EEDOPRK1 | |
| SCHEMBL9631586 | 0.81 | KCNH2 (0.50) | KCNH2SSTR5NR4A2EEDOPRK1 | |
| Fumaric Acid SCHEMBL9631171 | 0.80 | HTR1A (0.45) | KCNH2SSTR5NR4A2EEDOPRK1 | |
| Oxalic Acid SCHEMBL9630290 | 0.78 | EED (0.67) | KCNH2SSTR5NR4A2EEDOPRK1 | |
| Oxalic Acid SCHEMBL9630286 | 0.78 | EED (0.67) | KCNH2SSTR5NR4A2EEDOPRK1 | |
| SCHEMBL9629231 | 0.78 | EED (0.47) | KCNH2SSTR5NR4A2EEDOPRK1 | |
| SCHEMBL9629511 | 0.77 | NOS2 (0.46) | KCNH2SSTR5EEDOPRK1MEN1 | |
| SCHEMBL9687001 | 0.76 | KCNH2 (0.50) | KCNH2SSTR5NR4A2EEDOPRK1 | |
| Bromide SCHEMBL9698287 | 0.76 | NOS2 (0.51) | KCNH2SSTR5MEN1LMNAGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5151424-A | Antiallergens or antihistamines | JANSSEN PHARMACEUTICA N.V. (BE) | 1992-09-29 | — | — | US | disclosed |
| US-5071846-A | Anti-hystaminic [(bicyclic heterocyclyl) methyl and --hetero] substituted hexahydro-1H-azepines and pyrrolidines | JANSSEN PHARMACEUTICA N.V. (BE) | 1991-12-10 | — | — | US | disclosed |
| US-4988689-A | Antiallergens, antihistamines | JANSSEN PHARMACEUTICA N.V. (BE) | 1991-01-29 | — | — | US | disclosed |